EnkiLife Launches 1,900+ KO/KD Validated Antibodies to Advance Reliable and Reproducible Research
EnkiLife has officially launched its KO/KD Validated Antibody line, with every antibody tested against CRISPR/Cas9 knockout or siRNA knockdown lysates. Backed by raw validation images and over 1,900 validated targets, the launch targets the antibody reproducibility crisis head-on—giving researchers negative controls they can actually trust.
